Crizotinib hydrochloride
CAS: 1415560-69-8
Ref. 3D-QGC56069
10mg | A consultar | |
25mg | A consultar | |
50mg | A consultar | |
100mg | A consultar | |
250mg | A consultar |
Información del producto
Crizotinib hydrochloride (CZH) is an anti-cancer drug that inhibits the enzyme tyrosine kinase. It is a porphyrin-based molecule that has a linker to crizotinib, a cytotoxic agent. CZH has been approved for the treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in adults who have received at least one prior therapy. The effective dose of CZH is 400 mg twice per day. CZH has shown anticancer activity in vitro and in vivo and low toxicity.
Propiedades químicas
Consulta técnica sobre: 3D-QGC56069 Crizotinib hydrochloride
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.